Abstract
To compare the impact of maternal haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome, uncomplicated hypertension in pregnancy (HIP), and no hypertension (controls) on neonatal morbidity and mortality, 108 infants were matched with respect to gestational age, date of birth, and gender. The HELLP group infants had more grade 3 and 4 respiratory distress syndromes (36%) than the HIP group (19%) or controls (11%). Cardiovascular instability (arterial hypotension, volume resuscitation) was significantly more common in HELLP neonates (20% and 31%) than in HIP infants (9% and 6%) or controls (3% and 9%). Both, HELLP and HIP infants showed a higher incidence of growth retardation than the controls. After 32 weeks of gestation the incidence of severe neonatal morbidity was not different.
Conclusion Before 32 weeks of gestation both respir-atory and cardiovascular morbidity and intra-uterine growth retardation associated with HIP is further aggravated by a maternal HELLP syndrome.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 31 May 1996 / Received in revised form and accepted: 3 October 1996
Rights and permissions
About this article
Cite this article
Dötsch, J., Hohmann, M. & Kühl, P. Neonatal morbidity and mortality associated with maternal haemolysis elevated liver enzymes and low platelets syndrome. Eur J Pediatr 156, 389–391 (1997). https://doi.org/10.1007/s004310050621
Issue Date:
DOI: https://doi.org/10.1007/s004310050621